Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0F6WV
|
|||
| Former ID |
DCL000917
|
|||
| Drug Name |
PD-157695
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Schizophrenia [ICD-11: 6A20] | Preclinical | [1] | |
| Company |
Pfizer
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C13H10BrN3O4
|
|||
| Canonical SMILES |
C1=CC=C(C(=C1)NC(=O)NC2=C(C=C(C=C2)[N+](=O)[O-])O)Br
|
|||
| InChI |
1S/C13H10BrN3O4/c14-9-3-1-2-4-10(9)15-13(19)16-11-6-5-8(17(20)21)7-12(11)18/h1-7,18H,(H2,15,16,19)
|
|||
| InChIKey |
MQBZVUNNWUIPMK-UHFFFAOYSA-N
|
|||
| CAS Number |
CAS 182498-32-4
|
|||
| PubChem Compound ID | ||||
| PubChem Substance ID |
5591039, 7980570, 9993997, 14852033, 26759489, 41934772, 48110581, 49684195, 50112982, 50221429, 53788115, 53800548, 57356606, 85209285, 85787141, 97803300, 99431513, 103547644, 104082381, 106118934, 112404235, 121380087, 125333764, 125433058, 128631686, 134339365, 134340331, 134340490, 134340502, 134964511, 135293912, 135650994, 135698246, 139121540, 162023547, 163124986, 163687365, 167450927, 187071964, 196399953, 204360502, 208264769, 223427138, 223777318, 227354209, 252156740, 252457432, 252473340
|
|||
| ChEBI ID |
CHEBI:93074
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | The pipeline and future of drug development in schizophrenia. Mol Psychiatry. 2007 Oct;12(10):904-22. | |||
| REF 2 | Bisubstrate analogue inhibitors of 6-hydroxymethyl-7,8-dihydropterin pyrophosphokinase: synthesis and biochemical and crystallographic studies. J Med Chem. 2001 Apr 26;44(9):1364-71. | |||
| REF 3 | Interleukin-8 receptor antagonists in pulmonary diseases. Curr Opin Pharmacol. 2001 Jun;1(3):242-7. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.